Improving the customer onboarding experience in an increasingly competitive and congested financial services industry is vital for both legacy banks and those in fintech serious about growth... Guest ...

GlaxoSmithKline chief executive Emma Walmsley ... experience" – which may be an oblique reference to Walmsley's background in consumer health. According to the latter, shareholders "still ...

ELIQUENT Life Sciences (ELIQUENT), a global regulatory consulting firm, today announced the ...

Coherus BioSciences, Inc.’s CHRS share price has dipped by 12.59%, which has investors questioning if this is right time to ...

Holdings Inc. (NASDAQ: ARCT), a company specializing in mRNA medicines for infectious diseases and rare disorders, has appointed Dr. Moncef Slaoui as its Chair Designate. Dr. Slaoui, a notable figure ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Sustainable prospects for the majority of staff at the siteFirst staff takeovers and start of production at KNDS already planned for 2025 5 February, 2025 - The negotiations between Alstom and KNDS De ...